Annual report [Section 13 and 15(d), not S-K Item 405]

Other current assets (Details)

v3.25.1
Other current assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Other current assets    
Research and development credits receivable $ 12,929 $ 46,098
Prepayments 10,033 9,954
Clinical materials 59 1,329
VAT receivable 1,599  
Other current assets 3,170 2,412
Total $ 27,790 $ 59,793